On March 4, Shenzhen Star Silver Investment Group Co., Ltd. held a signing ceremony for the new polypeptide drug industrialization production base project in Xian \'an, Hubei Province.
It is reported that the project is in strict accordance with the United States FDA, the European Union and China GMP standards design and construction of modern pharmaceutical enterprises, the first phase of the project is located in Xian \'an economic development Zone, a total area of more than 300 acres, including headquarters conference, training, reception base, new peptide API production base, peptide preparation production base, information center and research and development center. New peptide drug industrial production base will be built in line with the EU, the United States and China GMP certification requirements of peptide drug API production base and Star Silver pharmaceutical headquarters conference, training, reception base, the Star Silver pharmaceutical new peptide drug industry base settled in Xian \'an will make due contributions to local economic development.